We compared hemostatic changes during OLT and HLT after various periods of graft storage, to investigate whether the host liver in HLT protects the recipient from hemostatic deterioration induced by severe graft storage damage. In particular, the mechanism of fibrinolytic deterioration was investigated. The effect of prostaglandin E1 (PGE1) on these parameters was also studied.
INTRODUCTION
Orthotopic liver transplantation (OLT) has become an accepted method to treat patients with end-stage chronic liver disease. However, the procedure is frequently complicated by severe changes in hemostasis. Both increased fibrinolysis 1'2 and disseminated intravascular coagulation 3'4' have been implicated in playing a role. The most striking abnormalities occur late in the anhepatic period and become more marked after reperfusion of the graft5 '6 . Earlier studies have demonstrated that the severity and duration of hemostasis abnormalities were mainly related to the quality of the donor liver7'S.Release of activated hemostasis factors and/or humoral substances from the graft, that may interfere with hemostasis have been suggested to play a role.
Auxiliary heterotopic liver transplantation (HLT) has been proposed as an alternative to hepatic replacement. In HLT, the host liver is left in situ and the graft is transplanted in a heterotopic position. The anhepatic period is avoided and the function of the host liver retained. Hence, substances released from the allograft at reperfusion might be cleared and the deterioration of hemostasis less severe. Recently, we demonstrated that changes in fibrinolysis after reperfusion and more severe and substained in OLT than in HLT after 2 hours of simple cold graft storage9. This suggested that the native liver in HLT protects the recipient from the changes induced by preservation damage. We were now interested in whether the host liver in HLT also protects the recipient from the effects of long-term preserved grafts as well as the mechanism of hemostatic deterioration. We have thereby concentrated on fibrinolysis and included, additionally to previous studies, t-PA activity measurement.
Graft protection by addition of prostagtandin E1 (PGE1) to Donor and recipient operations were performed as described earlier14. In OLT, a venovenous heparin-coated iliacoportajugular bypass was introduced15. Table 4 the causes of mortality are categorized. 
OL T HL T OL T HL T OL T HL T OL T HL T
Blood loss ml --median  400  500  850  425  160  1125  1100 925  --lowest  250  250  400  100  700  600  200  --highest  1800 1200  2200 700  1500  2000 1500   Blood  Transfusion ml  --median  --lowest  --highest   650  600  1000 600  750  1100  600  1000  450  400  200  500  900  450  375  2000 1100  1200 1200  1250  1000 1500 aThe blood loss in the 2 hr experiment is lower compared to the longer preservation groups (p=0.03).
bSignificantly different from OLT.
COnly one animal represented. In conclusion, it was demonstrated that in pigs changes in hemostasis after longterm graft storage are less dramatic in HLT compared to OLT. This suggests that HLT also protects the recipient from the effects of long-term preserved grafts.
Addition of PGE1 to the preservation fluid had no effect on the hemostatic changes in both OLT and HLT. Although these experiments are performed in the presence of a healthy host liver (although deprived from portal blood after the transplantation), while in the clinical situation the host liver is diseased, some remaining liver function is always present. The results are indicative of the benificial role of the (remnant function of the) host liver on hemostasis.
